Translational Molecular Nuclear Cardiology.

Area of Science:

• Nuclear medicine
• Molecular imaging
• Cardiovascular research

Background:

• Preclinical imaging availability is increasing, supporting novel molecular nuclear imaging agent development.
• Current nuclear cardiology radiotracers investigate key molecular processes in cardiovascular disorders.
• These processes include altered metabolism, ventricular remodeling, sympathetic activation, and inflammation.

Purpose of the Study:

• To highlight the role of preclinical imaging in developing new nuclear imaging agents.
• To emphasize the utility of current radiotracers in understanding cardiovascular disease mechanisms.
• To outline the requirements for effective translational molecular imaging.

Main Methods:

• Review of current radiotracer applications in nuclear cardiology.
• Discussion of molecular processes targeted in cardiovascular disorders.
• Analysis of the translational pathway for imaging compound development.

Main Results:

• Increased availability of preclinical imaging facilitates the creation of novel nuclear imaging agents.
• Existing radiotracers enable interrogation of critical molecular pathways in cardiovascular conditions.
• Coordination between clinical needs, tracer development, and molecular biology is crucial.

Conclusions:

• Advancements in preclinical imaging are foundational for developing new molecular nuclear imaging agents.
• Nuclear cardiology tools are vital for studying diverse cardiovascular disease mechanisms.
• Successful translational molecular imaging relies on integrating clinical needs with scientific development.